Live feed09:22:00·7mPRReleasevia QuantisnowBiofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full BodyByQuantisnow·Wall Street's wire, on your screen.BFRI· Biofrontera Inc.Health Care
